798 — Casper, Wyoming

798 is a clinical research site located in Casper, Wyoming, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

798 has participated in 1 clinical trials.

Therapeutic areas: Epilepsy, Monotherapy.

Sponsors: UCB BIOSCIENCES GmbH.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Casper

Browse all research sites in Wyoming · View every site in Casper

• Rocky Mountain Oncology
• GSK Investigational Site
• Care Access Research - Wyoming
• Local Institution - 121
• Pfizer Investigational Site
• Wyoming Medical Center
• Wyoming Brain and Spine Institute
• Novartis Investigative Site
• Care Access Research, Casper
• 089
• Central Wyoming Neurosurgery

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 798?

798 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 798 conducted?

798 has 1 clinical trials on record. Their work covers Epilepsy, Monotherapy.

Is 798 accredited by Crixeo Clinical Trials?

798 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 798?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.